Navigation Links
Health Robotics to Launch Germany's Installations of i.v.STATION(TM) at Charite-Universitatsmedizin Berlin
Date:7/20/2009

BOZEN, Italy, July 20 /PRNewswire/ -- Health Robotics today announced that it has signed a definitive agreement with Charite-Universitatsmedizin Berlin. Charite will install an i.v.STATION robot at its Centrum 14 during the second half of 2009.

The primary challenges in today's IV Admixture operations are serious medication errors, high costs, turn-around time, waste, regulatory issues, lack of audit trails, motion injuries, space constraints and difficulty in maintaining adequate and trained clinical staff. The i.v.STATION robot that automatically compounds non-hazardous IV doses and delivers them to the hospital staff in a ready-to-administer format for antibiotics, pain therapy, anti-virals, epidurals, and other IV and injectable doses. i.v.STATION was designed to address the above-mentioned industry-challenges, and to overcome the fact that until now, the range of products and technology available to mitigate these issues has consisted of variations on the IV "piggyback" bag, outsourcing of IVs, and mid-1990s-developed automated solutions that have seen very limited adoption and success.

"i.v.STATION represents a revolutionary approach in the quest for safe, accurate, efficient, and cost effective I.V. Admixtures. It offers unprecedented error reduction, accuracy and sterility benefits, nursing staff labor savings, all within a scalable and fail-safe architecture. We are delighted to be the first German hospital to test the exciting new technology of i.v.STATION robot," stated PD Dr. Hartmut Radtke, Chief of Production of Blood Products at Charite-Universitatsmedizin Berlin.

"We are ecstatic to have been selected by such a prestigious health care institution as Charite-Universitatsmedizin-Berlin, well known throughout the world for both its research and patient care excellence. It makes everyone at our company, especially those of us coming from Sud-Tirol very proud of what we have acco
'/>"/>

SOURCE Health Robotics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Anthony Hess to Lead SAIC Health Solutions Business Unit
2. avVaa World Health Care Products Inc. Announces Web Site Design for Neuroskin(R) Psoriasis Relief DRTV Campaign
3. American Medical Informatics Association (AMIA) Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certification
4. Health Robotics Expands and Diversifies Global Channel Strategies With Joint-Ventures & Direct Operations
5. avVaa World Health Care Products, Inc. Signs Agreement with 3PL Worldwide, Inc., for Order Management & Fulfillment for avVaas Product
6. avVaa World Health Care Products, Inc. Announces Engagement of Koeppel Direct for their DRTV-Direct Response Television Media Buying Campaign
7. Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer
8. BIO Ventures for Global Health Announces Management Changes
9. Expanding Indianas Breakthroughs in Health Information Technology (Exibhit Indiana): Initiative to Advance the States Health IT National Leadership and Assets Launched to Bring More Awareness to Sector
10. The MedZilla Report: May 2009 Employment Outlook for Biotech/Pharma/Health
11. Healthy Advice Networks Announces Improved Patient Outcomes in Physicians Offices with Healthy Advice Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Arlington, MA (PRWEB) December 18, 2014 ... products for ophthalmology and wound care. The National Eye ... has awarded LayerBio a Phase I SBIR grant to ... , Cataracts are the most common cause of vision ... cause of blindness worldwide. According to Dr. Ken Mandell, ...
(Date:12/19/2014)... December 19, 2014 The empty ... the rising ageing population and technological innovations in ... nutraceutical industries are catalysing the growth of the ... http://www.marketsandmarkets.com/Market-Reports/empty-capsules-market-218018190.html , Scope of Report , ... well as new entrants/smaller firms to gauge the ...
(Date:12/19/2014)... Dec. 18, 2014 Relmada Therapeutics, Inc. (OTCQB: ... treatment of chronic pain, announced the results of its ... "This was a transformational year in Relmada,s history and ... our company," said Sergio Traversa , chief executive ... executed on key financial, human resource and clinical development ...
(Date:12/17/2014)... RIDGE, N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today ... mg (referred to as Somatuline®) was approved by ... the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in ... locally advanced or metastatic disease to improve progression-free ...
Breaking Biology Technology:LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8
... ExonHit Therapeutics S.A.,(Alternext: ALEHT), a drug and ... its new SpliceArray(TM) for use in studying ... help our clients accelerate,and refine their therapeutic ... resolution expression profiling analysis, we identify novel,transcripts ...
... modern world, largely due to properties that render the ... One of their most useful qualities, however - the ... stress - is also one of the most puzzling., ... to change shape to absorb energy rather than breaking ...
... exterior of your house always looking good, without cleaning ... is now possible with paint that can maintain itself ... , A process for producing photo-catalytic, self-cleaning coatings ... for Science, Technology and Research), and licensed to Haruna ...
Cached Biology Technology:ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies 2ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies 3Fast molecular rearrangements hold key to plastic’s toughness 2Fast molecular rearrangements hold key to plastic’s toughness 3Photo-catalytic, self cleaning coating for building exteriors 2Photo-catalytic, self cleaning coating for building exteriors 3Photo-catalytic, self cleaning coating for building exteriors 4
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB ... Good Clinical Practices (GCP) audit to confirm its ... (FDA) regulations. This accomplishment enables HITLAB to conduct ... utilizing the highest principles for patient safety and ... improve global healthcare access, quality, and delivery with ...
(Date:12/17/2014)... 2014 Research and Markets ( ... "Global Chemical Sensor Market 2015-2019" report ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend upcoming ... medical sensors in biomedical applications. Chemical sensors help ... correct diagnosis during surgical procedures. The Global Chemical ...
(Date:12/15/2014)... 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is ... Facial recognition system measures the overall facial feature ... mouth, and the distance between eyes. Facial recognition ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... decay was once viewed as fossilization,s mortal enemy, but ... preserve the fossil record,s most vulnerable stuff -- animal ... scientists led by Indiana University Bloomington biologists Rudolf and ... cells by bacteria -- and the subsequent formation of ...
... We,ve all seen the satellite images of Earth at night--the ... humanity,s endless sprawl. These pictures are no longer just ... objectively measure it, according to a study in the December ... on geoscience and remote sensing. Travis Longcore, a USC ...
... California Institute of Technology has invited a longtime University ... research and presenting seminars on its campus. Fazle ... of Engineering, was the sole recipient of the Gordon ... year for Caltech,s division of engineering and applied sciences. ...
Cached Biology News:Bacterial biofilms as fossil makers 2Bacterial biofilms as fossil makers 3Light pollution offers new global measure of coral reef health 2Light pollution offers new global measure of coral reef health 3Celebrated UH researcher invited to Caltech as distinguished scholar 2